News All PostNewsAxxam enters CNS partnership with Lundbeck for Lead Identification6 December 2023read more >Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions15 November 2023read more >Ciriaco Maraschiello joins Axxam as Chief Operating Officer5 July 2023read more >Uwe Gottschalk appointed as Board Observer15 June 2023read more >Jörg Hüser joins Axxam as Chief Scientific Officer1 June 2023read more >Axxam and Promega announce agreement to develop smart assays for drug discovery services24 May 2023read more >Load MoreEnd of Content.
Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions15 November 2023read more >
Axxam and Promega announce agreement to develop smart assays for drug discovery services24 May 2023read more >
